Malignant melanoma is particularly resistant to conventional chemotherapy and radiotherapy. For this reason in the past years a huge variety of new compounds has been developed with potential chemotherapeutic activity which needs to be tested in vitro and in vivo. We investigated the in vitro action of three new experimental antifolate substances (MR7, MR21 and MR36) with a critical target for thymidylate synthase (TS), an essential enzyme for DNA synthesis. The response of two melanoma cell lines (SK-MEL-2 derived from malignant melanoma metastasis and SK-MEL-28 derived from primary malignant melanoma) was examined after treatment with these substances. The antifolate agents induced apoptosis in SK-MEL-2 and SK-MEL-28 cells as confirmed by the TUNEL technique and Comet Assay. Western-blot analysis showed a down-regulation of Bcl-2 protein level and PARP cleavage, otherwise p53 and Bax expressions were not modulated. Moreover, these antifolate-induced apoptosis was accompanied by both pro-caspase-9 and -8 activations. These results were supported by the use of the pan-caspases inhibitor Z-VAD-FMK that almost completely decreased the amount of apoptosis in both the melanoma cell lines treated with antifolate. In conclusion our results show that TS inhibitors are able to induce apoptosis through a caspase-mediated pathway, but without the involvement of the p53/Bax signalling. (c) 2006 Elsevier Ltd. All rights reserved.

New thymidylate synthase inhibitors induce apoptosis in melanoma cell lines / Giudice, Stefania; Benassi, Luisa; Bertazzoni, Giorgia; Costi, Maria Paola; A., Gelain; Venturelli, Alberto; Bernardi, Chiara; Gualdi, Giulio; A., Coppi; Rossi, Tiziana; Giannetti, Alberto; Magnoni, Cristina. - In: TOXICOLOGY IN VITRO. - ISSN 0887-2333. - STAMPA. - 21:2(2007), pp. 240-248. [10.1016/j.tiv.2006.09.023]

New thymidylate synthase inhibitors induce apoptosis in melanoma cell lines

GIUDICE, Stefania;BENASSI, Luisa;BERTAZZONI, Giorgia;COSTI, Maria Paola;VENTURELLI, Alberto;BERNARDI, Chiara;GUALDI, Giulio;ROSSI, Tiziana;GIANNETTI, Alberto;MAGNONI, Cristina
2007

Abstract

Malignant melanoma is particularly resistant to conventional chemotherapy and radiotherapy. For this reason in the past years a huge variety of new compounds has been developed with potential chemotherapeutic activity which needs to be tested in vitro and in vivo. We investigated the in vitro action of three new experimental antifolate substances (MR7, MR21 and MR36) with a critical target for thymidylate synthase (TS), an essential enzyme for DNA synthesis. The response of two melanoma cell lines (SK-MEL-2 derived from malignant melanoma metastasis and SK-MEL-28 derived from primary malignant melanoma) was examined after treatment with these substances. The antifolate agents induced apoptosis in SK-MEL-2 and SK-MEL-28 cells as confirmed by the TUNEL technique and Comet Assay. Western-blot analysis showed a down-regulation of Bcl-2 protein level and PARP cleavage, otherwise p53 and Bax expressions were not modulated. Moreover, these antifolate-induced apoptosis was accompanied by both pro-caspase-9 and -8 activations. These results were supported by the use of the pan-caspases inhibitor Z-VAD-FMK that almost completely decreased the amount of apoptosis in both the melanoma cell lines treated with antifolate. In conclusion our results show that TS inhibitors are able to induce apoptosis through a caspase-mediated pathway, but without the involvement of the p53/Bax signalling. (c) 2006 Elsevier Ltd. All rights reserved.
2007
21
2
240
248
New thymidylate synthase inhibitors induce apoptosis in melanoma cell lines / Giudice, Stefania; Benassi, Luisa; Bertazzoni, Giorgia; Costi, Maria Paola; A., Gelain; Venturelli, Alberto; Bernardi, Chiara; Gualdi, Giulio; A., Coppi; Rossi, Tiziana; Giannetti, Alberto; Magnoni, Cristina. - In: TOXICOLOGY IN VITRO. - ISSN 0887-2333. - STAMPA. - 21:2(2007), pp. 240-248. [10.1016/j.tiv.2006.09.023]
Giudice, Stefania; Benassi, Luisa; Bertazzoni, Giorgia; Costi, Maria Paola; A., Gelain; Venturelli, Alberto; Bernardi, Chiara; Gualdi, Giulio; A., Cop...espandi
File in questo prodotto:
File Dimensione Formato  
NEW TS 2007.pdf

Solo gestori archivio

Tipologia: Versione pubblicata dall'editore
Dimensione 1.73 MB
Formato Adobe PDF
1.73 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/612374
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 7
  • ???jsp.display-item.citation.isi??? 6
social impact